World’s First Lung Cancer Vaccine Trials Launched Across Seven Countries
The Guardian

In a first-of-its-kind clinical trial, an mRNA-based vaccine trains the patient's immune system to hunt down and kill cancerous cells and then prevents the cancer's return.
Spread the word